NASDAQ$MODVQ

Modivcare Inc · Q1 2024 earnings

Q1 2024 earnings · · Investor relations

Briefing

Modivcare's financial performance remained stable with revenue increase and strategic transformation progress.

Modivcare reported first quarter 2024 results in line with previously announced guidance, with revenue increasing by 3.3% year-over-year. The company is focused on strategic transformation, cost savings initiatives, and refinancing its 2025 senior unsecured notes.

  • Service revenue increased by 3.3% year-over-year to $684.5 million.
  • Net loss was $22.3 million, or $1.57 per diluted common share.
  • Adjusted EBITDA was $32.1 million, with an adjusted net loss of $1.2 million and adjusted EPS of negative $0.09.
  • The company won $171.2 million of NEMT total contract value during the quarter.

Headline financials

Total Revenue

$684M

Previous: $662M+3.3%
EPS

-$1.57

Previous: $1.42-210.6%
Adjusted Ebitda

$32.1M

No prior period
Net Cash Provided By Operating Activities

$9.56M

No prior period
Adjusted Net Loss

-$1.21M

No prior period
NEMT Total Paid Trips

8.8M

No prior period
NEMT Avg Monthly Members

29.1M

No prior period
PCS Total Hours

7.0M

No prior period
Monitoring Avg Monthly Members

249.0K

No prior period
Capital Expenditures

-$7.86M

Previous: -$13.3M+41.0%
Free Cash Flow

$1.7M

Previous: -$16M+110.7%
Net Income

-$22.3M

Previous: -$3.96M-462.8%
Operating Income

-$3.4M

Previous: $8.1M-141.9%
Gross Profit

$101M

Previous: $112M-10.0%
Cash & Equivalents

$10.3M

Previous: $12.8M-19.5%
Total Assets

$1.76B

Previous: $1.94B-9.1%
Stock-Based Comp

$2.01M

Previous: $1.12M+78.8%

Revenue & EPS history

Modivcare · Revenue · Quarterly

$684M

Q1 2024+3.3%vs Q1 2023
Beat estimate in 9 of 15 quarters(60%)
ActualEstimate

Forward guidance

Modivcare maintained its revenue and adjusted EBITDA guidance ranges for fiscal year 2024.

Tailwinds

  • Revenue is expected to be between $2.7 billion and $2.9 billion.
  • Adjusted EBITDA is expected to be between $190 million and $210 million.
  • Digital integration and technology enhancement initiatives are progressing.
  • Expected in-year cost savings of at least $34 million.
  • Confident in path to exit the fourth quarter of 2024 with expected run-rate adjusted EBITDA of $220 million to $230 million.

Headwinds

  • Guidance excludes the effects of any future merger or acquisition activity.
  • Guidance is based on the current operating environment.
  • Medicaid redetermination headwinds.
  • Recovery of utilization headwinds.
  • Working capital normalization headwinds.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 6 quarterly earnings reports · overlaid with Q1 2024

Historical avgQ1 2024

+0.1%

Avg return

Earnings day

-10.6%

Avg return

5 days after

+29.9%

Avg return

30 days after

53%

33 / 62 earnings

Positive

+21.0%

Q1 2024

Best reaction

-41.0%

Q4 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2025
Q2 2025
Q1 2025-11.4%-26.5%+198.5%
Q4 2024-22.5%-35.9%-68.1%
Q3 2024+10.6%-0.7%+11.3%
Q2 2024+15.8%+18.8%+59.8%
Q1 2024+21.0%+18.5%+23.0%
Q4 2023-41.0%-37.7%-44.9%
Q3 2023+14.5%
Q2 2023-4.4%
Q1 2023-21.6%
Q4 2022-1.6%
Q3 2022-5.9%
Q2 2022+2.0%
Q1 2022-7.2%
Q4 2021+16.5%
Q3 2021-8.8%
Q2 2021-1.2%
Q1 2021+2.0%
Q4 2020-15.4%
Q3 2020+4.1%
Q2 2020+8.8%
Q1 2020+7.9%
Q4 2019-9.2%
Q3 2019+5.2%
Q2 2019+2.6%
Q1 2019+2.3%
Q4 2018+0.1%
Q3 2018+11.4%
Q2 2018-9.3%
Q1 2018-6.3%
Q4 2017+7.6%
Q3 2017+5.2%
Q2 2017+0.0%
Q1 2017+10.3%
Q4 2016+8.8%
Q3 2016-7.0%
Q2 2016-1.7%
Q1 2016-0.8%
Q4 2015+16.3%
Q3 2015-14.6%
Q2 2015-0.8%
Q1 2015+12.2%
Q4 2014+9.9%
Q3 2014-11.3%
Q2 2014+17.8%
Q1 2014-2.7%
Q4 2013-10.4%
Q3 2013-11.7%
Q2 2013+0.7%
Q1 2013+6.7%
Q4 2012+5.1%
Q3 2012+16.4%
Q2 2012-14.7%
Q1 2011-0.9%
Q1 2012+0.6%
Q4 2009-2.2%
Q4 2011-2.2%
Q3 2010-2.3%
Q3 2011-2.3%
Q2 2011+4.3%
Q2 2010+4.3%
Q4 2010+4.3%
Q1 2010+1.4%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro